Totect - Ownership and Business Overview

Life ScienceCompany

Totect Ownership

Who owns Totect?

Totect is owned by Clinigen Group. It was acquired on March 2, 2016.

Totect Business Overview

Where is Totect headquartered?

Totect is headquartered in United States.

What sector is Totect in?

Totect is a life science company.

Life Science M&A Summary in 2016

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.

Join Mergr to view all 292 acquisitions of life science companies in 2016, including 31 acquisitions by private equity firms, and 261 by strategics.

Totect (dexrazoxane HCI)


United States,
www.totect.com

Totect (dexrazoxane HCI) is an emergency medicine used to reverse the toxic effects of anthracycline anti-cancer treatment. Totect® reverses this damage, allowing patients to continue their essential anti-cancer treatment.


 Subscribe to unlock this and 201,649
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.